A E Harper
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Pharmacology top 5%
- Pharmacology and Obesity Treatment
Papers in
-
- Diet and metabolism studies 4
-
- Pharmacology and Obesity Treatment 2
- Co-authors
- Arne Astrup (3 shared papers)L. Van Gaal (1 shared paper)Markku J. Savolainen (1 shared paper)MEJ Lean (2 shared papers)Raffaele Carraro (2 shared papers)Stephan Rössner (1 shared paper)Nick Finer (2 shared papers)Leo Niskanen (2 shared papers)
- Journals
- Obesity Reviews (3 papers)American Journal of Clinical Nutrition (1 paper)International Journal of Obesity (1 paper)PubMed (1 paper)
- Partner nations
- BelgiumUnited StatesUnited Kingdom
In The Last Decade
A E Harper
7 papers receiving 620 citations
A E Harper's Hit Papers
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 380
- Pharmacology 245
- Endocrine and Autonomic Systems 65
- Physiology 182
- Pharmacy 19
Countries citing papers authored by A E Harper
This map shows the geographic impact of A E Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A E Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A E Harper more than expected).
Fields of papers citing papers by A E Harper
This network shows the impact of papers produced by A E Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A E Harper. The network helps show where A E Harper may publish in the future.
Co-authors
The 13 scholars most cited alongside A E Harper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide Hit paper breakdown → | 2011 | 575 |
| 2 | 1978 | 47 | |
| 3 | 2005 | 26 | |
| 4 | 2004 | 10 | |
| 5 | 2004 | 5 | |
| 6 | ORIGINAL ARTICLE Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue | 2012 | 1 |
| 7 | Nutritional requirements and dietary allowances. | 1978 | 1 |
About A E Harper
A E Harper is a scholar working on Physiology, Pharmacology, Public Health, Environmental and Occupational Health, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 7 papers that have together received 665 indexed citations. Recurring topics across this work include Diet and metabolism studies (4 papers), Obesity, Physical Activity, Diet (2 papers), Diabetes Treatment and Management (2 papers), Pharmacology and Obesity Treatment (2 papers), Vitamin C and Antioxidants Research (1 paper), Muscle metabolism and nutrition (1 paper), Heart Failure Treatment and Management (1 paper) and Nutrition, Genetics, and Disease (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (380 citations), Pharmacology (245 citations), Endocrine and Autonomic Systems (65 citations), Physiology (182 citations) and Pharmacy (19 citations). A E Harper has collaborated with scholars based in Belgium, United States and United Kingdom. Frequent co-authors include Arne Astrup, L. Van Gaal, Markku J. Savolainen, MEJ Lean, Raffaele Carraro, Stephan Rössner, Nick Finer, Leo Niskanen, A Rissanen and Marie Kunešová. Their work appears in journals such as Obesity Reviews, American Journal of Clinical Nutrition, International Journal of Obesity and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.